Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API). Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. We study millions of patients and 5,000 more each day. With real-world medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood. The FDA has started to use real-world data to monitor postmarket safety and adverse events, and payers to support value-based payment program. The 21st Century Cures Act, passed in 2016, places additional focus on the use of real-world data to support regulatory decision making. These programs potentially contribute to the variability of the quantity and quality of evidence supporting recent drug approvals.Īll these suggest an ongoing need for continued evaluation of therapeutic safety and efficacy after drug approvals. When the drugs are approved and released in the market to a much bigger and ever-changing public, it is not uncommon for drugs to behave differently in the real world than in clinical trials.ĭuring the past 30 years, special regulatory programs are available to the FDA including Fast Track (1988, in statute 1997), Priority Review (1992), Accelerated Approval (1992), and Breakthrough Therapy designation (2012). The guidelines ensure that only a selected set of people are chosen due to time and costs. All clinical trials have guidelines about who can participate. New drugs have to go through a series of clinical trials before they are approved by the FDA. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 2.91%.Psoriasis (immune-mediated disease that affects the skin): 22 people, 4.57%.Pulmonary Embolism (blockage of the main artery of the lung): 24 people, 4.99%.Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 25 people, 5.20%.Haemoglobin Decreased: 55 people, 11.43%.Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 57 people, 11.85%.Nausea (feeling of having an urge to vomit): 64 people, 13.31%.Fatigue (feeling of tiredness): 65 people, 13.51%.Oedema Peripheral (superficial swelling): 72 people, 14.97%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |